×
About 20,868 results

ALLMedicine™ Irritable Bowel Syndrome Center

Research & Reviews  9,207 results

Fatigue in irritable bowel syndrome is associated with plasma levels of TNF-α and mesoc...
https://doi.org/10.1016/j.bbi.2020.11.035
Brain, Behavior, and Immunity; Norlin AK, Walter S et. al.

Nov 29th, 2020 - Irritable bowel syndrome (IBS) is a symptom-based disorder of gut-brain interactions generating abdominal pain. It is also associated with a vulnerability to develop extraintestinal symptoms, with fatigue often reported as one of the most disturbi...

Hypnotherapy for irritable bowel syndrome-type symptoms in patients with quiescent infl...
https://doi.org/10.1093/ecco-jcc/jjaa241
Journal of Crohn's & Colitis; Hoekman DR, Vlieger AM et. al.

Nov 27th, 2020 - Many inflammatory bowel disease (IBD) patients in remission have persisting symptoms, compatible with irritable bowel syndrome (IBS-type symptoms). We aimed to compare the effectiveness of gut-directed hypnotherapy versus standard medical treatmen...

Efficacy and safety of non-pharmacological interventions for irritable bowel syndrome i...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656202
World Journal of Gastroenterology; Dai YK, Wu YB et. al.

Nov 27th, 2020 - Although nonpharmacological interventions (NPI) for irritable bowel syndrome (IBS) have been applied clinically, their relative efficacy and safety are poorly understood. To compare and rank different NPI in the treatment of IBS. Five electronic d...

Patient factors influencing acute gluten reactions and cytokine release in treated coel...
https://doi.org/10.1186/s12916-020-01828-y
BMC Medicine; Tye-Din JA, Daveson AJM et. al.

Nov 26th, 2020 - Patients with coeliac disease (CD) commonly report a variety of adverse symptoms to gluten, but descriptions of the symptomatic response in the literature may have been confounded by the presence of food components such as fermentable carbohydrate...

Health Care Utilization, Transition Readiness, and Quality of Life: A Latent Class Anal...
https://doi.org/10.1093/jpepsy/jsaa099
Journal of Pediatric Psychology; Traino KA, Sharkey CM et. al.

Nov 25th, 2020 - To identify possible subgroups of health care utilization (HCU) patterns among adolescents and young adults (AYAs) with a chronic medical condition (CMC), and examine how these patterns relate to transition readiness and health-related quality of ...

see more →

Guidelines  37 results

Ardelyx Receives FDA Approval For Ibsrela® (Tenapanor), An NHE3 Sodium Transport Inhibitor, For The Treatment Of Irritable Bowel Syndrome With Constipation
http://ir.ardelyx.com/news-releases/news-release-details/ardelyx-receives-fda-approval-ibsrelar-tenapanor-nhe3-sodium

Sep 10th, 2019 - Ardelyx, Inc. (NASDAQ: ARDX), a specialized biopharmaceutical company focused on developing innovative first-in-class medicines to improve treatment for people with cardiorenal diseases, today announced that the U.S. Food and Drug Administration h...

AGA Technical Review on the Evaluation of Functional Diarrhea and Diarrhea-Predominant ...
https://doi.org/10.1053/j.gastro.2019.06.014
Gastroenterology Carrasco-Labra A, Lytvyn L et. al.

Jul 28th, 2019 - The evaluation of patients with chronic watery diarrhea represents a diagnostic challenge for clinicians because organic causes, including inflammatory bowel disease, microscopic colitis, and chronic infection, must be differentiated from function...

AGA Clinical Practice Guidelines on the Laboratory Evaluation of Functional Diarrhea an...
https://doi.org/10.1053/j.gastro.2019.07.004
Gastroenterology Smalley W, Falck-Ytter C et. al.

Jul 15th, 2019 - AGA Clinical Practice Guidelines on the Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D).|2019|Smalley W,Falck-Ytter C,Carrasco-Labra A,Wani S,Lytvyn L,|standards,diagnosis,etiology,p...

AGA Guideline on the Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D)
https://www.gastrojournal.org/article/S0016-5085(19)41083-4/fulltext?referrer=https%3A%2F%2Fwww.jwatch.org%2Fna49679%2F2019%2F08%2F09%2Ftesting-functional-diarrhea-and-diarrhea-predominant

Jul 10th, 2019 - This document presents the official recommendations of the American Gastroenterological Association (AGA) on the Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) in Adults. The guideline was de...

Irritable Bowel Syndrome (IBS)
https://www.niddk.nih.gov/health-information/digestive-diseases/irritable-bowel-syndrome

Mar 31st, 2019 - Irritable bowel syndrome (IBS) is a group of symptoms that occur together, including repeated pain in your abdomen and changes in your bowel movements, which may be diarrhea, constipation, or both. With IBS, you have these symptoms without any vis...

see more →

Drugs  461 results see all →

Clinicaltrials.gov  10,261 results

Fatigue in irritable bowel syndrome is associated with plasma levels of TNF-α and mesoc...
https://doi.org/10.1016/j.bbi.2020.11.035
Brain, Behavior, and Immunity; Norlin AK, Walter S et. al.

Nov 29th, 2020 - Irritable bowel syndrome (IBS) is a symptom-based disorder of gut-brain interactions generating abdominal pain. It is also associated with a vulnerability to develop extraintestinal symptoms, with fatigue often reported as one of the most disturbi...

Hypnotherapy for irritable bowel syndrome-type symptoms in patients with quiescent infl...
https://doi.org/10.1093/ecco-jcc/jjaa241
Journal of Crohn's & Colitis; Hoekman DR, Vlieger AM et. al.

Nov 27th, 2020 - Many inflammatory bowel disease (IBD) patients in remission have persisting symptoms, compatible with irritable bowel syndrome (IBS-type symptoms). We aimed to compare the effectiveness of gut-directed hypnotherapy versus standard medical treatmen...

Efficacy and safety of non-pharmacological interventions for irritable bowel syndrome i...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656202
World Journal of Gastroenterology; Dai YK, Wu YB et. al.

Nov 27th, 2020 - Although nonpharmacological interventions (NPI) for irritable bowel syndrome (IBS) have been applied clinically, their relative efficacy and safety are poorly understood. To compare and rank different NPI in the treatment of IBS. Five electronic d...

Patient factors influencing acute gluten reactions and cytokine release in treated coel...
https://doi.org/10.1186/s12916-020-01828-y
BMC Medicine; Tye-Din JA, Daveson AJM et. al.

Nov 26th, 2020 - Patients with coeliac disease (CD) commonly report a variety of adverse symptoms to gluten, but descriptions of the symptomatic response in the literature may have been confounded by the presence of food components such as fermentable carbohydrate...

Health Care Utilization, Transition Readiness, and Quality of Life: A Latent Class Anal...
https://doi.org/10.1093/jpepsy/jsaa099
Journal of Pediatric Psychology; Traino KA, Sharkey CM et. al.

Nov 25th, 2020 - To identify possible subgroups of health care utilization (HCU) patterns among adolescents and young adults (AYAs) with a chronic medical condition (CMC), and examine how these patterns relate to transition readiness and health-related quality of ...

see more →

News  873 results

Multidisciplinary Approach Bests Specialist Care for Functional GI Problems
https://www.medscape.com/viewarticle/935117

Aug 4th, 2020 - NEW YORK (Reuters Health) - For patients with irritable bowel syndrome and other functional gastrointestinal disorders, a multidisciplinary team approach was more effective and less costly than gastroenterologist-only care in an open-label, single...

Postcolonoscopy Antibiotics Linked With IBS
https://www.staging.medscape.com/viewarticle/931491

May 31st, 2020 - Antibiotic exposure within 14 days after screening colonoscopy may increase risk of irritable bowel syndrome (IBS), based on a retrospective analysis of more than 400,000 individuals. Antibiotic use in the 2 weeks leading up to colonoscopy also tr...

Postcolonoscopy Antibiotics Linked With IBS
https://www.medscape.com/viewarticle/931491

May 31st, 2020 - Antibiotic exposure within 14 days after screening colonoscopy may increase risk of irritable bowel syndrome (IBS), based on a retrospective analysis of more than 400,000 individuals. Antibiotic use in the 2 weeks leading up to colonoscopy also tr...

Fast Five Quiz: Cannabis Use and Abuse
https://reference.medscape.com/viewarticle/927888_2

Apr 7th, 2020 - Answer 1/5 Although further investigation is still needed, cannabis use currently has the strongest scientific support in treating which of the following? Your peers chose: Irritable bowel syndrome 0% Spasticity associated with multiple sclerosis ...

Probably okay to skip SIBO breath test before starting rifaximin in IBS-D
https://www.mdedge.com/clinicianreviews/article/218759/gastroenterology/probably-okay-skip-sibo-breath-test-starting?channel=53
M. Alexander Otto

Mar 10th, 2020 - MAUI, HAWAII – The problem with doing a breath test for small intestinal bacterial overgrowth before starting rifaximin (Xifaxan) for diarrhea-predominant irritable bowel syndrome is that you can’t trust the results, according to IBS expert Lin Ch.

see more →

Patient Education  29 results see all →